FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
K.Quik liquid (Vitaflo International Ltd) 225 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely dexibuprofen 300 milligram/1 each conventional release oral tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Waymade Healthcare Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Genus Pharmaceuticals) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Dexibuprofen 300mg tablets 60 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Waymade Healthcare Plc) 60 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) 60 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Genus Pharmaceuticals) 60 tablet 6 x 10 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets blackcurrant (Bayer Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lorazepam 1mg/ml oral solution (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ketoconazole 200mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets blackcurrant (Bayer Plc) 15 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lorazepam 1mg/ml oral solution (A A H Pharmaceuticals Ltd) 150 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ketoconazole 200mg tablets (Alliance Healthcare (Distribution) Ltd) 60 tablet 6 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Milpharm Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Milpharm Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GlucoRx CarePoint hypodermic insulin needles for pre-filled / reusable pen injectors screw on 10mm/29gauge (GlucoRx Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GlucoRx CarePoint hypodermic insulin needles for pre-filled / reusable pen injectors screw on 10mm/29gauge (GlucoRx Ltd) 100 needle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefalexin 125mg/5ml oral suspension sugar free (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension sugar free (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension sugar free (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefalexin 125mg/5ml oral suspension sugar free (Alliance Healthcare (Distribution) Ltd) 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension sugar free (Alliance Healthcare (Distribution) Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension sugar free (A A H Pharmaceuticals Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucosamine hydrochloride 750mg capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cytoplan Glucosamine hydrochloride 750mg capsules (Cytoplan Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucosamine hydrochloride 750mg capsules 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucosamine hydrochloride 750mg capsules 500 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucosamine hydrochloride 750mg capsules (Ardern Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucosamine hydrochloride 750mg capsules 180 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nature's Own Glucosamine hydrochloride 750mg capsules (Nature's Own Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cytoplan Glucosamine hydrochloride 750mg capsules (Cytoplan Ltd) 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nature's Own Glucosamine hydrochloride 750mg capsules (Nature's Own Ltd) 180 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cytoplan Glucosamine hydrochloride 750mg capsules (Cytoplan Ltd) 180 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nature's Own Glucosamine hydrochloride 750mg capsules (Nature's Own Ltd) 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nature's Own Glucosamine hydrochloride 750mg capsules (Nature's Own Ltd) 500 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucosamine hydrochloride 750mg capsules (Ardern Healthcare Ltd) 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cefalexin 125mg/5ml oral suspension sugar free (A A H Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cefalexin 125mg/5ml oral suspension sugar free (A A H Pharmaceuticals Ltd) 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (RX Farma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (RX Farma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (RX Farma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (RX Farma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (RX Farma) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (RX Farma) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (RX Farma) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (RX Farma) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prilocaine 100mg/5ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prilotekal 100mg/5ml solution for injection ampoules (Goldshield Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prilocaine 100mg/5ml solution for injection ampoules 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prilotekal 100mg/5ml solution for injection ampoules (Goldshield Pharmaceuticals Ltd) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lactose powder 25 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lactose powder (Special Order) 25 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Neon Verifine Safety lancets 2.4mm/21gauge (Neon Diagnostics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Primidone 250mg/5ml oral suspension 150 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Primidone 250mg/5ml oral suspension (Drug Tariff Special Order) 150 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Neon Verifine Safety lancets 2.4mm/21gauge (Neon Diagnostics Ltd) 100 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levobupivacaine 1.25mg/mL injection solution 200mL bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely clozapine 50 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clozapine 200mg tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chirocaine 250mg /200ml solution for injection bags (Abbott Laboratories Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clozapine 50mg tablets 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clozapine 50mg tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Denzapine 50mg tablets (Merz Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clozapine 200mg tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levobupivacaine 250mg/200ml solution for injection bags 12 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Denzapine 200mg tablets (Merz Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clozapine 200mg tablets 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chirocaine 250mg /200ml solution for injection bags (Abbott Laboratories Ltd) 12 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Denzapine 50mg tablets (Merz Pharma UK Ltd) 50 tablet 5 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Denzapine 200mg tablets (Merz Pharma UK Ltd) 50 tablet 5 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Denzapine 200mg tablets (Britannia Pharmaceuticals Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Denzapine 50mg tablets (Britannia Pharmaceuticals Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Panzyga 5g/50ml solution for infusion bottles (Octapharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Panzyga 10g/100ml solution for infusion bottles (Octapharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Panzyga 5g/50ml solution for infusion bottles (Octapharma Ltd) 1 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Panzyga 10g/100ml solution for infusion bottles (Octapharma Ltd) 1 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 400mg/200ml infusion bags (Bowmed Ibisqus Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 400mg/200ml infusion bags 5 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 400mg/200ml infusion bags (Bowmed Ibisqus Ltd) 5 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely morphine sulfate 15 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely morphine sulfate 30 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 200mg/100mL intravenous injection solution 100mL premixed bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Paracetamol 1g tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chloroprocaine 50mg/5ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 200mg/100ml solution for injection bags (Mayne Pharma Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Paracetamol 1g tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Morphine sulfate 30mg suppositories 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 200mg/100ml solution for injection bags 1 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Morphine sulphate 15mg suppositories (Martindale Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Paracetamol 1g tablets (Dawa Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Morphine sulphate 15mg suppositories 12 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Morphine sulphate 15mg suppositories (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ampres 50mg/5ml solution for injection ampoules (Mercury Pharma Group Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Morphine sulfate 15mg suppositories 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Morphine sulfate 15mg suppositories (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Morphine sulphate 30mg suppositories (Aurum Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Panadol OA 1000mg tablets (Haleon UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 77 of 86 Next End

This concept is not in any reference sets

Back to Start